Objectives: Among patients with suspected infection, a single measurement of the quick Sepsis-related Organ Failure Assessment has good predictive validity for sepsis, yet the increase in validity from repeated measurements is unknown. We sought to determine the incremental predictive validity for sepsis of repeated quick Sepsis-related Organ Failure Assessment measurements over 48 hours compared with the initial measurement. Design: Retrospective cohort study. Setting: Twelve hospitals in southwestern Pennsylvania in 2012. Patients: All adult medical and surgical encounters in the emergency department, hospital ward, postanesthesia care unit, and ICU. Interventions: None. Measurements and Main Results: Among 1.3 million adult encounters, we identified those with a first episode of suspected infection. Using the maximum quick Sepsis-related Organ Failure Assessment score in each 6-hour epoch from onset of suspected infection until 48 hours later, we characterized repeated quick Sepsis-related Organ Failure Assessment with: 1) summary measures (e.g., mean over 48 hr), 2) crude trajectory groups, and 3) group-based trajectory modeling. We measured the predictive validity of repeated quick Sepsis-related Organ Failure Assessment using incremental changes in the area under the receiver operating characteristic curve for in-hospital mortality beyond that of baseline risk (age, sex, race/ethnicity, and comorbidity). Of 37,591 encounters with suspected infection, 1,769 (4.7%) died before discharge. Both the mean quick Sepsis-related Organ Failure Assessment at 48 hours (area under the receiver operating characteristic, 0.86 [95% CI, 0.85–0.86]) and crude trajectory groups (area under the receiver operating characteristic, 0.83 [95% CI, 0.83–0.83]) improved predictive validity compared with initial quick Sepsis-related Organ Failure Assessment (area under the receiver operating characteristic, 0.79 [95% CI, 0.78–0.80]) (p
from Emergency Medicine via xlomafota13 on Inoreader https://ift.tt/2w64s7a
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Abstract Ravulizumab (ravulizumab-cwvz; ULTOMIRIS™), a humanized monoclonal antibody, is a complement C5 inhibitor developed by Alexion Ph...
-
Clinical Kidney Journal from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/28LkrhW
-
Visit www.feniex.com to learn more. In episode 4 of Feniex Focus, Katya explains the exciting new Feniex Fusion emergency vehicle lights. ...
-
http://bit.ly/2TO0eLw
-
Objectives: Little is known about the ongoing mortality risk and healthcare utilization among U.S. children after discharge from a hospitali...
-
Abstract Purpose To analyze the differences in outcomes between primary and secondary definitive osteosynthesis for fractures of the lower...
-
Type of Opportunity: Full Time FTE: 1.000000 Exempt: No Work Schedule: Varied Days and Hours Shift: 1 Location: US:NM:Albuquerque Education:...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου